Serum aminoterminal propeptide of type III procollagen (S-PIIINP) and hepatobiliary dysfunction in patients with ulcerative colitis

References

• Shepherd H A, Selby W S, Chapman R GW, Nolan D, Barbatis C, McGee JO'D. Ulcerative colitis and persistent liver dysfunction. Q J Med 1983; 208: 503–13
   Google Scholar
• Rasmussen H H, Fallingborg J, Mortensen P B, Freund L, Tage-Jensen U, Kruse V. Primary sclerosing cholangitis in patients with ulcerative colitis. Scand J Gastroenterol 1992; 27: 732–6
   PubMed Web of Science ®Google Scholar
• Olsson R, Danielsson A, Järnerot G, Lindström E, Lööf L, Rolny P. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319–23
   PubMed Web of Science ®Google Scholar
• Schrumpf E, Fausa O, Kolmannskog F, Elgjo K, Ritland S, Gjone E. Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand J Gastroenterol 1982; 17: 33–9
   PubMed Web of Science ®Google Scholar
• Wiesner R H, LaRusso N F. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 2000–6
   Web of Science ®Google Scholar
• Chapman R WG, Arborgh BÅM, Rhodes J M, Summerfield J A, Dick R, Scheuer P J. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870–7
   PubMed Web of Science ®Google Scholar
• Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts. Ann Intern Med 1985; 102: 581–7
   PubMed Web of Science ®Google Scholar
• Ludwig J. Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol 1989; 13: 43–9, Suppl 1
   PubMed Web of Science ®Google Scholar
• Melkko J, Hellevik T, Risteli L, Risteli J, Smedbrød B. Clearance of the aminoterminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 1994; 179: 405–12
   PubMed Web of Science ®Google Scholar
• Niemelä O, Risteli L, Sotaniemi S O, Risteli J. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. Gastroenterology 1983; 85: 254–9
   PubMed Web of Science ®Google Scholar
• Frei A, Zimmerman A, Weigand K. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 1984; 4: 830–4
   PubMed Web of Science ®Google Scholar
• Eriksson S, Zettervall O. The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis. J Hepatol 1986; 2: 370–8
   PubMed Web of Science ®Google Scholar
• Davis B, Madri J. Type I and type< III procollagen peptides during hepatic fibrogenesis. An immunohistochemical and ELISA serum study in the CC14 rat model. AJP 1987; 1: 137–47
   Google Scholar
• McCullough A, Stassen W, Wiesner R, Czaja A J. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity. Hepatology 1987; 7: 49–54
   PubMed Web of Science ®Google Scholar
• Höckerstedt K, Risteli L, Salmela K, Risteli J. Serum type III procollagen as a marker in liver transplantation. Transplant Proc 1990; 4: 1574–5
   Google Scholar
• Stassen W N, Wiesner R H, McCullough A J, Beaver S J, Tavill A S, Ludwig J. Serum levels of procollagen III: an index of fibrogenesis in primary sclerosing cholangitis. Hepatology 1984; 5: 1057
   Google Scholar
• Mehal W Z, Snook J A, Rudenski A, Kay J DS, Chapman R W. Procollagen III peptide as an indicator of hepatic fibrogenesis in primary sclerosing cholangitis. Eur J Gastrol Hepatol 1992; 4: 937–41
   Google Scholar
• Risteli J, Risteli L. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol 1995; 22: 77–81, Suppl 2
   PubMed Web of Science ®Google Scholar
• Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat A P, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715–18
   PubMed Web of Science ®Google Scholar
• Truelove S C. Natural history of ulcerative colitis. Inflammatory bowel disease. 1st ed, R N Allan, M RB Keighley, J Alexander-Williams, C Hawkins. Churchill Livingstone, Birmingham 1984; 94–100
   Google Scholar
• Welin S, Welin G. The double contrast examination of the colon. Experiences with the Welin modification. Thieme, Tubingen 1976; 82–97
   Google Scholar
• Nixon J B, Riddel R H. Histopathology of ulcerative colitis. Inflammatory bowel disease. 1st ed., R N Allan, M RB Keighley, J Alexander-Williams, C Hawkins. Churchill Livingstone, Birmingham 1983; 194–209
   Google Scholar
• Truelove S C, Witts J L. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955; 2: 1041–8
   PubMed Web of Science ®Google Scholar
• Haukipuro K, Melkko J, Risteli L, Kairaluoma M I, Risteli J. Connective tissue response to major surgery and postoperative infection. Eur J Clin Invest 1992; 22: 333–40
   PubMedGoogle Scholar
• Oikarinen A, Autio P, Vuori J, Väänänen K, Risteli L, Kiistala U. Systemic glucocorticoid treatment decreases serum concentrations of car-boxyterminal propeptide of type I procollagen (PICP) and aminoterminal propeptide type III procollagen (PIIINP) in dermatological patients. Br J Dermatol 1992; 126: 172–8
   PubMed Web of Science ®Google Scholar
• Metz C. Basic principles of ROC analysis. Semin Nuclear Med 1978; 4: 283–98
   Google Scholar
• Lupinetti M, Mehigan D, Cameron J L. Hepatobiliary complications of ulcerative colitis. Am J Surg 1980; 139: 113–18
   PubMedGoogle Scholar
• Boberg K M, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E. Hepatobiliary diseases in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol 1994; 29: 744–52
   PubMed Web of Science ®Google Scholar
• Broome U, Glauman H, Hultcrantz R. Liver histology and follow-up of 68 patients with ulcerative colitis and normal liver function tests. Gut 1990; 31: 468–72
   PubMed Web of Science ®Google Scholar
• Olsson R, Hägerstrand I, Broome U, Danielsson A, Jarnerot G, Lööf L. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol 1995; 48: 933–5
   PubMed Web of Science ®Google Scholar